Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
Trial record 2 of 1770 for:    PC trial

A Randomized Controlled Trial on EGBD vs PC for Acute Cholecystitis. (DRAC)

This study is currently recruiting participants. (see Contacts and Locations)
Verified November 2016 by Chinese University of Hong Kong
Sponsor:
Collaborators:
American Society for Gastrointestinal Endoscopy
Tokyo Medical University
Kinki University
University of Barcelona
Information provided by (Responsible Party):
Anthony Teoh, Chinese University of Hong Kong
ClinicalTrials.gov Identifier:
NCT02212717
First received: August 5, 2014
Last updated: November 16, 2016
Last verified: November 2016
  Purpose

Acute cholecystitis commonly occurs in elderly patients that are high-risk candidates for surgery. Percutaneous cholecystostomy (PC) is frequently employed for gallbladder drainage in these patients. Recently, the feasibility of EUS-guided gallbladder drainage (EGBD) in treatment of this condition has been demonstrated but how the two procedures compare to one another is uncertain.

The aim of this study is to compare EGBD versus PC as a definitive treatment, in high-risk patients suffering from acute cholecystitis in a randomized controlled trial. We hypothesize that EGBD can reduce the morbidity, re-intervention and mortality when compared to PC.


Condition Intervention Phase
Acute Cholecystitis
Procedure: EUS-guided gallbladder drainage (EGBD)
Procedure: Percutaneous cholecystostomy (PC)
Phase 2
Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Endosonography-guided Gallbladder Drainage (EGBD) Versus Percutaneous Cholecystostomy (PC) in Patients Suffering From Acute Cholecystitis That Are Unsuitable for Surgery. A Randomized Controlled Trial.

Resource links provided by NLM:


Further study details as provided by Chinese University of Hong Kong:

Primary Outcome Measures:
  • Composite outcome of all morbidities, re-interventions and mortalities [ Time Frame: 2 years ] [ Designated as safety issue: Yes ]

Secondary Outcome Measures:
  • Technical success [ Time Frame: 30 days ] [ Designated as safety issue: Yes ]
    Technical success is defined as the ability to access and drain the gallbladder by placement of a drainage tube or stent.

  • Pain scores [ Time Frame: 7 days ] [ Designated as safety issue: No ]
    Pain assessment would be performed using the visual-analogue scale (1 to 100) on post-procedural days 1 to 7.

  • Analgesic requirements [ Time Frame: 7 days ] [ Designated as safety issue: No ]
    The amount of analgesic consumed during admission will be recorded and compared between groups. Oral panadol and intravenous tramadol (or equivalent) would be provided as required to patients.

  • Stone clearance rates [ Time Frame: 2 years ] [ Designated as safety issue: No ]
    The presence or absence of gallstones after 2 years would be assessed by abdominal ultrasonography

  • Clinical success [ Time Frame: 30 days ] [ Designated as safety issue: Yes ]
    Clinical success is obtained when the patient is afebrile and had more than 20% decrease in white cell counts.


Estimated Enrollment: 60
Study Start Date: August 2014
Estimated Study Completion Date: August 2018
Estimated Primary Completion Date: June 2017 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: EUS-guided gallbladder drainage Procedure: EUS-guided gallbladder drainage (EGBD)
The gallbladder would be identified by a linear echoendoscope (EUS) and a suitable puncture site in the stomach or the duodenum without intervening blood vessels would be located. The gallbladder would be punctured with a 19-gauge needle and a guidewire would be passed through the needle and looped in the gallbladder. The Hot AXIOS stent would then be inserted. A naso-gallbladder drain or a 5-7Fr double pigtail stents can be inserted into gallbladder if the effluent failed to clear after irrigation. This would be performed to improve drainage and avoid obstruction of the stent.
Active Comparator: Percutaneous cholecystomy Procedure: Percutaneous cholecystostomy (PC)
Trained interventional radiologists in the respective hospitals would perform the procedure under local anesthesia. A transhepatic route would be used in all patients to decrease bile leakage. An 8.5 Fr pigtail drainage catheter would be placed between the 8th or 9th intercostal space under sonographic and fluoroscopic guidance. The pigtail catheter would be drained to a bedside bag.

  Eligibility

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Consecutive patients aged ≥ 18 years old admitted for acute cholecystitis but are unsuitable for early laparoscopic cholecystectomy due to poor premorbid conditions including: American society of anesthesiology grading ≥ 3, APACHE score ≥ 12, limited life expectancy (less than 2 years) or deemed unsuitable for general anesthesia would be included.
  • Written informed consent from patient or guardian who is able to understand the nature and possible consequences of the study

Exclusion Criteria:

  • Pregnancy
  • Patients unwilling to undergo follow-up assessments
  • Patients with suspected gangrene or perforation of the gallbladder
  • Patients diagnosed with concomitant liver abscess or pancreatitis (defined as elevated serum amylase more than three times the upper limit of normal)
  • Altered anatomy of the upper gastrointestinal tract due to surgery of the esophagus, stomach and duodenum
  • Patients with liver cirrhosis, portal hypertension and/or gastric varices
  • Abnormal coagulation: INR > 1.5 and/or platelets < 50.000/mm3
  • Previous drainage of the gallbladder
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT02212717

Contacts
Contact: Anthony Y Teoh, FRCSEd(Gen) 26322956 anthonyteoh@surgery.cuhk.edu.hk

Locations
China, Hong Kong
Chinese University of Hong Kong Recruiting
Hong Kong, Hong Kong, China
Contact: Anthony Y Teoh, FRCSEd(Gen)    26322956    anthonyteoh@surgery.cuhk.edu.hk   
Principal Investigator: Anthony Y Teoh, FRCSEd(Gen)         
Japan
Kinki University Hospital Recruiting
Osaka, Japan
Contact: Masayuki Kitano, MD         
Principal Investigator: Masayuki Kitano, MD         
Tokyo Medical University Hospital Active, not recruiting
Tokyo, Japan
Spain
University Hospital Rio Hortega Active, not recruiting
Barcelona, Spain
Sponsors and Collaborators
Chinese University of Hong Kong
American Society for Gastrointestinal Endoscopy
Tokyo Medical University
Kinki University
University of Barcelona
  More Information

Publications:
Responsible Party: Anthony Teoh, Honorary Associate Professor, Chinese University of Hong Kong
ClinicalTrials.gov Identifier: NCT02212717     History of Changes
Other Study ID Numbers: CREC-2014.301-T 
Study First Received: August 5, 2014
Last Updated: November 16, 2016
Health Authority: Joint CUHK-NTEC Clinical Research Ethics Committee: Hong Kong

Keywords provided by Chinese University of Hong Kong:
Acute cholecystitis
EUS-guided gallbladder drainage
Percutaneous cholecystostomy

Additional relevant MeSH terms:
Cholecystitis
Acalculous Cholecystitis
Cholecystitis, Acute
Gallbladder Diseases
Biliary Tract Diseases
Digestive System Diseases

ClinicalTrials.gov processed this record on December 08, 2016